Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
Journal of Veterinary Pharmacology and Therapeutics
|
June 27, 2012
The margin of safety of a single application of transdermal fentanyl solution when administered at multiples of the therapeutic dose to laboratory dogs
M C Savides, R C Pohland, D A Wilkie, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
December 19, 2013
The safety and effectiveness of a long-acting transdermal fentanyl solution compared with oxymorphone for the control of postoperative pain in dogs: a randomized, multicentered clinical study
S A Martinez, M G Wilson, D D Linton, et al.
Clinical Pharmacokinetics
|
September 18, 2016
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Kevin J Freise, Aksana K Jones, Doerthe Eckert, et al.
Clinical Pharmacology and Therapeutics
|
April 13, 2007
Change in erythropoietin pharmacokinetics following hematopoietic transplantation
J A Widness, R L Schmidt, R J Hohl, et al.
Clinical Pharmacology and Therapeutics
|
August 5, 2020
Integrated Mechanistic Model of Minimal Residual Disease Kinetics With Venetoclax Therapy in Chronic Lymphocytic Leukemia
Sathej Gopalakrishnan, William Wierda, Brenda Chyla, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
November 10, 2007
Development and validation of the maximal electro-shock seizure model in dogs
P R Territo, K J Freise, K Newhall, et al.
Expert Review of Anticancer Therapy
|
July 1, 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC
Pierre Peterlin, Esma Saada-Bouzid, Mor Moskovitz, et al.
Transfusion
|
January 11, 2012
Comparison of red blood cell survival in sheep determined using red blood cells labeled with either biotin at multiple densities or [14C]cyanate: validation of a model to study human physiology and disease
Donald M Mock, Nell I Matthews, Shan Zhu, et al.
Transfusion
|
June 22, 2010
Red blood cell (RBC) volume can be independently determined in vivo in the sheep using ovine RBCs labeled at different densities of biotin
Donald M Mock, Nell I Matthews, Shan Zhu, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
November 13, 2008
Nonlinear mixed effects pharmacokinetic/pharmacodynamic analysis of the anticonvulsant ameltolide (LY201116) in a canine seizure model
P R Territo, H E Shannon, K Newhall, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
Journal of Veterinary Pharmacology and Therapeutics
|
June 27, 2012
The margin of safety of a single application of transdermal fentanyl solution when administered at multiples of the therapeutic dose to laboratory dogs
M C Savides, R C Pohland, D A Wilkie, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
December 19, 2013
The safety and effectiveness of a long-acting transdermal fentanyl solution compared with oxymorphone for the control of postoperative pain in dogs: a randomized, multicentered clinical study
S A Martinez, M G Wilson, D D Linton, et al.
Clinical Pharmacokinetics
|
September 18, 2016
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Kevin J Freise, Aksana K Jones, Doerthe Eckert, et al.
Clinical Pharmacology and Therapeutics
|
April 13, 2007
Change in erythropoietin pharmacokinetics following hematopoietic transplantation
J A Widness, R L Schmidt, R J Hohl, et al.
Clinical Pharmacology and Therapeutics
|
August 5, 2020
Integrated Mechanistic Model of Minimal Residual Disease Kinetics With Venetoclax Therapy in Chronic Lymphocytic Leukemia
Sathej Gopalakrishnan, William Wierda, Brenda Chyla, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
November 10, 2007
Development and validation of the maximal electro-shock seizure model in dogs
P R Territo, K J Freise, K Newhall, et al.
Expert Review of Anticancer Therapy
|
July 1, 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC
Pierre Peterlin, Esma Saada-Bouzid, Mor Moskovitz, et al.
Transfusion
|
January 11, 2012
Comparison of red blood cell survival in sheep determined using red blood cells labeled with either biotin at multiple densities or [14C]cyanate: validation of a model to study human physiology and disease
Donald M Mock, Nell I Matthews, Shan Zhu, et al.
Transfusion
|
June 22, 2010
Red blood cell (RBC) volume can be independently determined in vivo in the sheep using ovine RBCs labeled at different densities of biotin
Donald M Mock, Nell I Matthews, Shan Zhu, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
November 13, 2008
Nonlinear mixed effects pharmacokinetic/pharmacodynamic analysis of the anticonvulsant ameltolide (LY201116) in a canine seizure model
P R Territo, H E Shannon, K Newhall, et al.
Page
of 13